Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Krystal Biotech, Inc.

Get SEC filing alerts via email and in your feed for Krystal Biotech, Inc.

KRYS

Krystal Biotech, Inc.

About Krystal Biotech, Inc.

Krystal Biotech is a biotechnology company specializing in gene therapies for rare and serious diseases. Using its proprietary HSV-1 platform, it develops and commercializes treatments like VYJUVEK for dystrophic epidermolysis bullosa and pipeline candidates for ophthalmology, respiratory, oncology, and dermatology. The company focuses on non-invasive, repeatable gene delivery to address high unmet medical needs globally.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Krystal Biotech, Inc.

1
1
Krystal Biotech, Inc. Krystal Biotech Reports 32% Revenue Growth to $116.4 Million in Latest Quarter

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
Krystal Biotech, Inc. Krystal Biotech Reports $204.8 Million Net Income for 2025, Driven by VYJUVEK Success

Via official filing (AI summary) | 4 months ago | 0 comments

3
1
Krystal Biotech, Inc. Krystal Biotech Reports 17% Revenue Growth to $97.8 Million in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Krystal Biotech, Inc. Krystal Biotech Reports 37% Revenue Growth to $96M in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Krystal Biotech, Inc. Krystal Biotech Reports 95% Revenue Growth and $35.7 Million Net Income in Latest Quarter

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Krystal Biotech, Inc. Krystal Biotech Reports $89.2 Million Net Income for 2024, Driven by VYJUVEK Sales

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
Krystal Biotech, Inc. Krystal Biotech Reports Significant Financial Growth, Revenue Surge in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments